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Wanted: Posters
Members of the Washington University 
School of Medicine community gathered 
at the sixth annual Research Training 
Symposium and Poster Session held in 
October at the School of Medicine’s Farrell 
Learning and Teaching Center. The event 
showcases basic, clinical and translational 
research projects by junior faculty, fellows, 
residents and training program students. 
It is cosponsored by the Clinical Research 
Training Center (CRTC) — a component 
of the university’s Institute of Clinical 
and Translational Sciences (ICTS) — and 
the Office of Medical Student Research. 
The ICTS is part of a national consortium 
of medical research institutions working 
together to improve the way biomedical 
research is conducted across the country.
View enhanced content online:  
outlook.wustl.edu   
Like the School of Medicine on Facebook:  
facebook.com/WUSTLmedicine.health   
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ports medicine specialists at the School 
of Medicine are leading a national study 
analyzing why a second surgery to 
reconstruct a tear in the knee’s anterior cruciate  
ligament (ACL) carries a high risk of bad outcome.
More than 200,000 ACL reconstructions are 
performed each year in the United States, and  
1 percent to 8 percent fail for some reason. Most 
patients then opt to have their knee ligament 
reconstructed a second time, but the failure rate 
on subsequent surgeries is nearly 14 percent.
The Washington University group received a 
$2.6 million grant from the National Institute of 
Arthritis and Musculoskeletal and Skin Diseases 
and is leading dozens of surgeons across the 
nation in one of the largest orthopedic, multi-
center studies ever conducted: the MARS study 
(Multicenter ACL Revision Study).
“If I reconstruct the ACL in your knee, and 
you go back to sports, and three years later you 
pivot on a basketball court and tear it again, 
that subsequent surgery often does not have 
results equal to the original surgery,” says Rick 
W. Wright, MD, the Dr. Asa C. and Mrs. Dorothy 
W. Jones Professor in Orthopaedic Surgery and 
the MARS study’s principal investigator.
During ACL reconstruction, surgeons some-
times replace the torn knee ligament with a 
ligament transplanted from a cadaver. In other 
cases, the surgeon will move a piece of the 
hamstring muscle or the patellar tendon and 
attach it in place of the torn ligament.
Wright, who also is co-chief of Washington 
University’s Sports Medicine Service and an 
orthopedic surgeon at Barnes-Jewish Hospital, 
and his colleagues are recruiting patients with 
a second ACL tear for the MARS study. The 
surgeons will note the condition of the knee 
and how the original surgery was performed 
to see whether that predicts problems with a 
subsequent operation. They also will make note 
of the surgical technique and source of the ACL 
graft used in the initial reconstruction.
The surgeons will compare rehabilitation 
techniques and whether particular approaches 
are related to better or worse outcomes. Patients 
will be surveyed about their knee function, the 
general state of their health, and their quality of 
life before and after a second ACL surgery.
S
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fixing knees
Although mostly a sports injury,  
ACL tears — often caused by pivoting  
or landing from a jump — can also  
occur during rough play, motor  




















Second ACL repairs aren’t  
always successful — why?
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A glimpse of DNA   Undergraduate students visiting  
St. Louis for the Annual Biomedical Research Conference for 
Minority Students examine slides of DNA at the Genome Institute. 
The national conference, held in November, is designed to encourage  
undergraduate, post-baccalaureate and graduate underrepresented 
minority students to pursue advanced training in the biomedical 
and behavioral sciences. Washington University, under the leadership 
of its Division of Biology and Biomedical Sciences, hosted a visit for 
about 200 students. At the School of Medicine, they toured the Hope 
Center for Neurological Disorders, the Knight Alzheimer’s Disease 
Research Center, the Center for Clinical Imaging Research, and the  








PSA testing remains viable for some
A dra recommendation by the U.S. Preventive Services Task 
Force calling for an end to routine PSA testing for healthy 
men age 50 and older goes too far, says a prostate cancer 
expert at the Alvin J. Siteman Cancer Center at Washington 
University School of Medicine and Barnes-Jewish Hospital.
“Mass screening is not the way  
to go,” says Gerald L. Andriole,  
MD, chief of urologic surgery,  
who acknowledges that wide- 
spread testing has led many men 
with slow-growing tumors to be 
overdiagnosed and overtreated. 
“We have to take a more nuanced 
approach to determine which men 
should be screened in the first place, 
how frequently they should be 
tested, and whether their cancer 
warrants therapy.”
Andriole, who also is the principal investigator of the 
National Cancer Institute’s Prostate, Lung, Colorectal and 
Ovarian (PLCO) screening trial, argues that it would be a 
mistake to universally dismiss the PSA test. Rather, he says 
the decision to screen should be le up to patients and their 
doctors, who should take into consideration a man’s overall 
health, age and other risk factors.
 
“Routine annual PSA screening 
is not necessary for most men. 
But men with a high risk of 
dying from prostate cancer — 
particularly African Americans 
and those with a family history 
of prostate cancer — should 
still be screened.”
 — Gerald L. Andriole, MD
Washington University in St. Louis has received a five-year,  
$3 million grant to establish a new center to develop better 
ways to prevent and treat type 2 diabetes in high-risk patients, 
including American Indians and Alaska Natives.
Funding for the Center for Diabetes Translation Research 
comes from the National Institute of Diabetes and Digestive 
and Kidney Diseases (NIDDK) at the National Institutes of 
Health (NIH). Washington University is one of seven insti-
tutions awarded funding to establish this type of center.
“e center is a unique opportunity to make sure cutting-
edge science has an impact on real-world settings,” says Debra 
Haire-Joshu, PhD, professor of public health at the university’s 
Brown School and the School of Medicine and director of 
the new center. “is grant will enable us to support research 
that addresses the root causes of diabetes and disparities.”
Type 2 diabetes is the most 
common form of diabetes, 
according to the American 
Diabetes Association. Millions of 
Americans have been diagnosed 
with high blood sugar — a hall-
mark of the disease — and many 
more are at risk of the disease 
because they are older, over-
weight or have a family history 
of the disease. Le untreated, 
high blood sugar can lead to complications such as eye, 
nerve, kidney and heart damage.
American Indians and Alaska Natives have the highest  
diabetes prevalence of all U.S. racial and ethnic groups, 
according to the Centers for Disease Control and Prevention. 
e two groups are twice as likely as white adults to suffer 
from type 2 diabetes.
e center has four cores. e health communication and 
health literacy core will evaluate the best ways to communi-
cate information to improve diabetes prevention and care. A 
second core will focus on how to translate research discover-
ies into better treatments and prevention. Another core will 
address health and economic policy, and the fourth core will 
support investigators working with American Indian and 
Alaska Native communities.
e new center will serve as a resource for investigators at 
Saint Louis University, the University of Missouri School of 
Journalism, and the National Congress of American Indians.
“Our goal,” says Haire-Joshu, “is to significantly improve 
the prevention and care of diabetes in populations at 
increased risk of this devastating disease.”
New diabetes research center  
to focus on high-risk patients
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Two leading members of the faculty have been named Alan 
A. and Edith L. Wolff Professors in their respective fields. 
Raphael Kopan, PhD, has been named the Wolff Professor of 
Developmental Biology, and L. David Sibley, PhD, has been 
named the Wolff Professor of Molecular Microbiology.
“Raphael Kopan’s research is revealing new details of how 
an important protein guides the development of many of 
the body’s tissues,” says Larry J. Shapiro, MD, executive vice 
chancellor for medical affairs and 
dean of the School of Medicine. 
“David Sibley studies a common 
parasite’s role in causing illness, 
helping develop new insights into 
its deadly microbial sibling, the 
malaria parasite.”
Kopan joined Washington 
University as an assistant professor 
of medicine and of molecular  
biology and pharmacology. He 
studies a protein called Notch that 
is instrumental in guiding embry-
onic cells’ development into the body’s many tissue types. 
Because Notch is present in so many cell types, Kopan’s  
lab has contributed to medical research across an array of  
disciplines, from Alzheimer’s disease to asthma to cancer.
Sibley was recruited as an assistant professor of molecular 
microbiology and was promoted to full professor in 2002. 
His lab focuses on Toxoplasma gondii, a parasite that may 
infect as many as one in every four 
humans. e parasite rarely causes 
symptoms but can become a poten-
tially life-threatening infection if 
the immune system is weakened by 
illnesses such as HIV or suppressed 
to facilitate an organ transplant.
Sibley’s studies reveal how 
Toxoplasma and its relatives, 
including the malaria parasite 
Plasmodium falciparum, infect 
cells in the human body and  
hence cause disease.
e late Alan and Edith Wolff supported medical research 
at the School of Medicine for more than three decades. In 
2007, Edith Wolff gave $20 million to Washington University 
School of Medicine to establish the Alan A. and Edith L. 
Wolff Institute, supporting biomedical research projects 
leading to the prevention, treatment and cure of disease.
Kopan, Sibley named to Wolff 
professorships in their fields
Honored for key medical research
L. David Sibley, PhD
Raphael Kopan, PhD
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easuring oxygen during eye 
surgery, investigators at the 
School of Medicine have 
discovered a potential explanation of why 
African Americans have a higher risk of  
glaucoma than Caucasians.
They found that oxygen levels are signifi-
cantly higher in the eyes of African Americans 
with glaucoma than in Caucasians with the 
disease. The researchers, who reported their 
findings in the July issue of the Archives of 
Ophthalmology, suspect that more oxygen 
may damage the eye’s drainage system, 
resulting in elevated pressure that can  
damage the optic nerve, causing blindness.
The study provides the first physiologic 
clue about the link between race and risk for 
glaucoma. Compared to Caucasians, glau-
coma is about six times more common in 
African Americans, and blindness caused by 
glaucoma is roughly 16 times more likely.
“Our findings suggest there may be 
physiologic differences in oxygen metabolism 
between African Americans and Caucasians,” 
says first author Carla J. Siegfried, MD. “In our 
African-Americans’ risk for glaucoma
M








studies, we were not looking specifically at 
African Americans, but the racial difference in 
oxygen levels was significant, and we believe 
this observation deserves further study.”
Siegfried, professor of ophthalmology 
and visual sciences, says it’s not surprising 
that oxygen may play a big role in the devel-
opment of glaucoma because it may be a 
source of free radicals that damage cells. Like 
cataracts, glaucoma is a disease associated 
with aging. Oxidative stress, an imbalance 
between these free radicals and antioxidants, 
is linked to the aging process and many other 
age-related conditions like cardiovascular and 
neurodegenerative diseases.
“We began studying oxygen in the eye 
after our basic studies showed that it was 
tightly regulated there, with the lowest lev-
els near the lens,” says David C. Beebe, PhD, 
the Janet and Bernard Becker Professor of 
Ophthalmology and Visual Sciences and 
professor of cell biology and physiology. 
“Clinical studies with Nancy Holekamp [MD, 
professor of clinical ophthalmology and 
visual sciences] and Ying-Bo Shui [MD, PhD, 
senior scientist] revealed that exposure 
of the lens to excess oxygen caused the 
most common kind of cataracts. And our 
discovery about cataracts led us, somewhat 
surprisingly, to glaucoma. Dr. Siegfried 
then joined us, confirming the connec-
tion between oxygen and glaucoma, and 
the link between oxygen and race was yet 
another surprise.”
Siegfried says it is not yet possible to say 
whether the elevated oxygen levels cause 
pressure to rise and optic nerve damage 
to occur. Her team has received a four-year 
grant from the National Eye Institute to  
further investigate that association.
Glaucoma is the 
leading cause of 
blindness among 
African Americans.
Fresh faces   Members of 
the medical school Class of 2015 
gathered in August at the School 
of Medicine’s annual White Coat 
Ceremony, at which they donned 
their white coats — long a symbol 
of the medical profession — and 
recited a newly penned class oath. 
Other programs, including the 
Division of Biology and Biomedical 
Sciences and the Programs in 
Occupational Therapy, Physical 
Therapy, and Audiology and 
Communication Sciences, held 
welcome celebrations that offered 
students the opportunity to meet 
one another as well as program 
faculty and staff.
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Luis A. Sanchez, MD, has been named the inaugural Gregorio 
A. Sicard Distinguished Professor of Vascular Surgery.
Sanchez is highly regarded for his expertise in vascular 
and endovascular surgery. He joined Washington University 
in 1999 as an associate professor of surgery and radiology. In 
2011, he was named chief of the section of vascular surgery at 
the School of Medicine and Barnes-Jewish Hospital.
“Like Greg Sicard, Dr. Sanchez is an internationally known 
innovator of endovascular surgery,” says Timothy J. Eberlein, 
MD, the Bixby Professor and head of the Department of 
Surgery, the Spencer T. and 
Ann W. Olin Distinguished 
Professor and director of 
the Alvin J. Siteman Cancer 
Center at Barnes-Jewish 
Hospital and Washington 
University School of 
Medicine. “His contributions 
have helped transform the 
field. We are looking forward 
to his leadership of our 
program in vascular surgery 
and keeping it the national leader that it is.”
Gregorio A. Sicard, MD, for whom the professorship is 
named, is the Eugene M. Bricker Chair of Surgery at Barnes-
Jewish Hospital. Sicard has spent his entire medical career at 
Washington University, with numerous leadership roles in the 
Department of Surgery. He is now the department’s executive 
vice chairman.
Sanchez named Sicard professor
Luis A. Sanchez, MD, left, and Gregorio A. Sicard, MD
Washington University in St. Louis has licensed to Castle 
Biosciences Inc. the exclusive use of a gene to detect the 
spread of cancer in melanoma patients.
A link between the BAP1 gene and cancer metastasis was 
discovered by Washington University scientists J. William 
Harbour, MD, an ophthalmologic oncologist, and Anne M. 
Bowcock, PhD, a geneticist. eir research, published in 2010 
in the journal Science, showed that BAP1 mutations occurred 
in 84 percent of melanomas that developed in the eye and later 
spread, but were rare in eye tumors that did not metastasize.
e researchers also have identified one individual with 
a germline BAP1 mutation, indicating that this mutation 
can be inherited and give 
rise to a familial cancer 
syndrome. Mutations in 
the BAP1 gene have been 
found in skin melanomas, 
mesotheliomas, menin-
giomas and cancers of  
the breast, ovary, kidney 
and lung.
Harbour, the Paul 
A. Cibis Distinguished 
Professor of Ophthal-
mology and Visual 
Sciences, and Bowcock, 
professor of genetics, pediatrics and medicine, worked 
closely with the university’s Office of Technology Manage- 
ment, which filed patents related to the BAP1 discovery,  
giving the university the option to license the technology.
“is is a win-win situation for the university,” says 
Bradley J. Castanho, PhD, director of the university’s Office 
of Technology Management. “Licensing the technology  
maximizes the opportunities for WUSTL scientists and the  
university to take this discovery to the market, where it could 
be developed into a diagnostic test for cancer metastasis.”
Castle Biosciences, based in Texas, is validating the BAP1 
technology for use in both ocular melanoma and melanoma 
that develops on the skin. e company plans to incorporate 
BAP1 as a target in a clinical test for melanoma metastasis. 
e new license is the second between the university and 
Castle Biosciences for technology developed by Harbour. e 
first exclusive license, in 2009, was related to technology to 
predict the risk of metastasis in patients with ocular mela-
noma. e company has completed technical and clinical 
validation studies, and the assay is now part of the standard 
of care for patients with the disease.
Licensed gene linked to cancer 
spread in melanoma patients
















A cancerous melanoma tumor (dark area, 
upper right) is seen below the retina. 
Hands-on health care  Mogboluwaga Oginni, left, 
learns how to apply a cast from orthopedic technician Jamie Palmer 
and April Nortrup, practice office manager of Orthopedic Tech 
Services located in the Center for Advanced Medicine. Oginni, a  
St. Louis University High School graduate now in his freshman year 
at Creighton University, recently spent six weeks at the School of 
Medicine as part of a paid internship program affiliated with the 
East Central Missouri Area Health Education Center. An aspiring 
physician, he was exposed to every aspect of Washington University 
Orthopedics — from shadowing physicians as they repaired shattered 


















have shown that a device 
approved by the Food and Drug 
Administration to reduce the risk that 
patients will recall their surgery does not 
lower the risk of the problem, known as 
intraoperative awareness, any more than a 
less expensive method.
The new study, published Aug. 18 in The 
New England Journal of Medicine, involved 
more than 6,000 surgical patients at 
Washington University School of Medicine, 
the University of Chicago and the University 
of Manitoba in Winnipeg.
Unintended intraoperative awareness, 
also known as anesthesia awareness, occurs 
when a patient becomes aware during sur-
gery and remembers being in pain or feel-
ing distress during the operation. Between 
one in 500 and one in 1,000 surgery 
patients experience awareness during anes-
thesia. Those with such memories often 
need psychological help, and some even 
develop post-traumatic stress disorder.
Preventing memory of surgery   Cheaper option is better
A N E S T H E S I O L O G Y
“We were testing whether a protocol 
based on a device called a bispectral index 
or BIS monitor, which measures brain 
activity to determine how deeply a patient 
is anesthetized, could more effectively 
prevent intraoperative awareness than an 
alternative approach that measures anes-
thetic levels in a patient’s breath,” says first 
author Michael S. Avidan, MB, BCh,  
professor of anesthesiology.
The study, called the international BIS 
or Anesthetic Gas to Reduce Explicit Recall 
(BAG-RECALL) trial, focused on a subset of 
patients at high risk for awareness. They 
include patients undergoing cardiac sur-
gery, those who regularly consume large 
amounts of alcohol or take sedatives or 
certain types of pain-killing drugs. Patients 
who previously have had episodes of 
awareness also are at high risk.
Because the study showed that the 
structured approach to using BIS monitor-
ing is no better than one based on mea-
suring exhaled anesthetics, Avidan and 
co-investigator Alex S. Evers, MD, the Henry 
E. Mallinckrodt Professor and head of the 
Department of Anesthesiology, say the cur-
rent, widespread use of the bispectral index 
in operating rooms should be re-examined.
“New technology has to prove its supe-
riority over more cost-effective alternatives,” 
Avidan explains. “Our trial showed, com-
pellingly, that the protocol based on the 
bispectral index is not superior.”
Outlook  7outlook.wustl.edu
The bispectral index (BIS) monitor tracks brain activity. 
Tread the Med is on the move    
A new walking initiative sponsored by the School of 
Medicine’s Wellness Committee attracted about 1,200 
people to its official launch in September. Dean Larry J. 
Shapiro, MD, left center, James P. Crane, MD, associate vice 








Evans, human resources consultant (not pictured), led the 
group on a brief walk around Hudlin Park to kick off the 
program. Designed to encourage members of the medical 
school community to incorporate more walking into their 
lives, thereby improving overall health, Tread the Med 
boasts 118 teams with more than 2,000 participants.
more information
healthyliving.wustl.edu
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it takes  
 a team
Two minimally invasive techniques 
in one procedure — an effective option 
for a common heart arrhythmia
B Y  J U L I A  E V A N G E L O U  S T R A I T
A S  H E  S AW E D  A  B AC K YA R D  T R E E ,  
Steve Gaal felt his heart start to race, and some-
how it didn’t feel right. Over the next month he 
experienced more of these worrisome episodes. 
Sometimes the frantic beats stopped aer a few  
minutes; other times they lasted more than an hour. 
“If I was walking up stairs when it started, I 
could finish the staircase,” he says. “I could force 
myself through it, but I felt like I shouldn’t do any-
thing while it was happening. Most of the time, I 
would just sit and wait for it to run its course.”
An active retiree, the former president and  
CEO of Delta Dental of Missouri sought the advice 
of his doctor, who referred him to a cardiologist. A 
heart monitor revealed the problem — atrial fibril-
lation, the heart’s most common irregular beat.
8  Washington University School of Medicine Winter 2011
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Pioneers in surgical techniques 
for treating atrial fibrillation, 
from left: Hersh S. Maniar, MD, 
Ralph J. Damiano Jr., MD, Mitch 
N. Faddis, MD, PhD, and Phillip S. 
Cuculich, MD. Inset: Patient  
Steve Gaal and his wife, Gina.
Aer standard treatments failed, Gaal’s doctors at the 
School of Medicine suggested a new “hybrid” procedure. e 
approach combines minimally invasive surgical techniques 
with the latest advances in catheter ablation, a technique that 
applies scars to the heart’s inner surface to block the signals 
that cause the heart to misfire. e two-pronged approach 
gives doctors access to both the inside and outside of the 
heart at the same time, helping to more completely block the 
erratic electrical signals that cause atrial fibrillation.
Atrial fibrillation affects more than 2 million Americans. 
While not fatal in itself, patients who suffer from atrial fibril-
lation are at increased risk of stroke and congestive heart 
failure. And many, especially those like Gaal who feel the 
fibrillations, have shortness of breath, chest pain, fatigue and 
feelings of anxiety, among other problems.  
“For some patients, it’s a difficult way to live,” says  
Phillip S. Cuculich, MD, assistant professor of medicine and 
a cardiac electrophysiologist who treats patients with atrial 
fibrillation at Barnes-Jewish Hospital.
Atrial fibrillation occurs when the upper chambers of the 
heart, called atria, get irregular electrical signals that disrupt 
the coordinated pumping of blood through the heart to the 
rest of the body. Instead of a normal beat, these signals cause 
the heart to quiver, preventing adequate blood flow to the 
ventricles, the heart’s main pumps.
Despite its prevalence, atrial fibrillation remains tricky 
to treat. Medications that maintain a normal heart rhythm 
oen stop working aer a period of time. 
“I tried medication,” Gaal says. “ey thought it was 
working. But within a day or two aer they released me from 
the hospital, I felt the fibrillations starting up again.”
When medication fails, doctors typically recommend 
catheter ablation, which involves threading long, thin  
tubes through a vein in the groin into the heart. e tips of 
these catheters can be heated, allowing doctors to perform  
a series of ablations, or burns, on the heart’s inner surface.  
e goal of ablation therapy is to create scar tissue that  
isolates the irregular electrical signals and blocks them from  
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Steve Gaal tries out his 
newly revised heart.
spreading over the heart and causing fibril-
lation. Aer a catheter ablation procedure, 
about 70 percent of patients remain free of 
symptoms aer one year. 
Although success rates for catheter ablation 
are higher than medication, it doesn’t always work; 
some patients may require a second or third procedure 
to achieve a successful result. And it does not work well for 
patients with an enlarged le atrium, like Gaal. 
For these hard-to-treat patients, doctors may recommend  
the Cox-Maze surgical procedure, developed in 1987 by 
James L. Cox, MD, at Washington University.
With a high success rate, the Cox-Maze procedure is 
considered the gold standard of atrial fibrillation treatment. 
e original Cox-Maze procedure has been refined by Ralph 
J. Damiano Jr., MD, the John M. Shoenberg Professor of 
Surgery, and is effective in 90 percent of patients. Damiano 
has made the procedure easier to perform and more widely 
available. But many patients consider it too invasive. 
“If you have other open-heart cardiac surgery that you 
need, like bypass surgery or valve surgery, and you have 
atrial fibrillation, the Cox-Maze procedure is an excellent 
choice to do at the same time,” Cuculich says. “But most  
of my patients just have atrial fibrillation.”
Aer medication failed and since he had no other heart 
problems, Gaal’s doctors determined he would be a good 
candidate for the hybrid procedure. Available at only a hand-
ful of U.S. medical centers, the hybrid approach attempts to 
recreate the success rates of the Cox-Maze procedure with 
the minimally invasive nature and shorter recovery times 
associated with catheter ablation. 
Because catheters enter through a vein, electrophysiolo-
gists only have access to the inside of the heart. A surgeon, 
in contrast, can provide access to the outside. 
“By applying the energy to make scars from both the 
inside and outside of the heart, we’re better able to achieve 
a full-thickness ablation,” says Hersh S. 
Maniar, MD, assistant professor of surgery, 
who performs the new hybrid procedure and 
the Cox-Maze. “A complete scar that crosses 
through the full thickness of the heart wall will 
more permanently block atrial fibrillation signals.” 
To avoid open surgery, the hybrid procedure is 
performed through three small incisions under both of the 
patient’s armpits. e surgeons view their work by inserting 
a small camera into one of the incisions.  
Aer the surgeon has performed the ablations on the out-
side of the heart, the electrophysiologist uses the catheters 
inside the heart to attempt to induce a fibrillation, testing the 
integrity of the ablation lines. If the atrial fibrillation persists, 
the electrophysiologist can touch up the ablation lines inside 
the heart until fibrillation can no longer be induced. Finally, 
the surgeon closes off the le atrial appendage, the area of the 
heart where most stroke-causing blood clots originate. 
A clinical trial is planned to compare the new hybrid 
procedure to catheter ablation in patients whose atrial fibril-
lation is persistent, meaning it does not start and stop on 
its own, and whose le atrium is enlarged. is group of 
patients has not done well historically with catheter ablation.
But outside the clinical trial, the procedure is now avail-
able to any patient with atrial fibrillation aer consultation 
with his or her doctor.  
“Right now we’re doing this for people who have persis-
tent atrial fibrillation and for people who have had a failed 
catheter ablation procedure,” Cuculich says. “I think this is 
an important step forward in improving patient quality of 
life in a less invasive way than traditional surgery.”
Gaal is pleased with the results. 
“I’ve had no recurrences of the fibrillations since the  
procedure,” he says. “I feel good and I know in the next  
few months I’m going to be that much better. I’m looking 
forward to it.”
Phillip S. Cuculich, MD, left, and 
Hersh S. Maniar, MD, display 
the tools that make a “hybrid” 
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Ins & Outs 
Washington University physicians at Barnes-Jewish 
Hospital pioneered the surgical treatment of atrial 
fibrillation. The original procedure involved opening 
the chest, stopping the heart and applying a “maze” 
of incisions. Although this proved highly effective, 
researchers continued to seek less disruptive 
approaches. Incisions can be replaced by controlled 
scars, called ablations, created with electrical currents 
applied in or on the beating heart. However, the 
limited depth of such scarring permits tissue to regrow, 
and fibrillation can recur. Now, a team of specialists has 
joined forces to perform inner and outer ablations 
during one minimally invasive surgery, offering 
effective treatment and quicker recovery.
Outside the heart
A surgeon performs a  
series of ablations on the 
heart’s outer surface  
(step 1, right). These burns 
surround the pulmonary 
veins, where the erratic 
signals that cause atrial 
fibrillation often originate. 
Inside the heart
An electrophysiologist 
uses catheters to perform 
ablations on the inner 
surface (2) to further 
contain the signals.  
Final steps
The electrophysiologist 
tests the heart to see if 
fibrillation is impeded; 
more work may be needed 
(see below). Lastly, the 
surgeon removes the left 
atrial appendage (3), a 
point of origin for blood 





Red shows that 
fibrillation is fully 
blocked; the gap 






S U R G E O N  
Operates an electrical  
clamp on the heart
E L E C T R O - 
P H YS I O LO G I S T  
Inserts electrical 
catheters through 
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After 
        MD            B Y  H O L L Y  E D M I S T O N 
Rebecca P. McAlister, MD, far left, and  
Tia O. Drake, far right, meet regularly 
with residents, fellows and their  
program directors to discuss issues 
related to postgraduate clinical training.
at effort is headed by Rebecca P. McAlister, 
MD, professor of obstetrics and gynecology and 
associate dean for graduate medical education, and 
Tia O. Drake, director, graduate medical education.
“e job of the ACGME and our office is to 
ensure that our programs meet established  
standards,” says McAlister. “We ensure that we  
maintain a quality educational environment for  
all upper-level trainees in any of the residency  
and clinical fellowship training programs at the  
university or our affiliated hospitals.”
e GME office heads the Washington University 
Barnes-Jewish Hospital St. Louis Children's Hospital 
Educational Consortium. Postgraduate trainees can 
be employed at any of the three institutions, but the 
oversight for the educational environment resides 
with the GME office, while the hospitals focus on 
patient care and the physical environment.
“Our primary goal is to ensure that the people 
we turn out at the end of their training are com-
petent in an array of areas,” says Drake. "ese 
include their medical knowledge, their profession-
alism, and their ability to communicate."
Medical school may teach  the basics, but it is post– graduate education that  
truly prepares young physicians to  
independently practice medicine.  
e Accreditation Council for  
Graduate Medical Education (ACGME)  
is the main accrediting body for U.S. 
residency and fellowship programs. 
At Washington University School of 
Medicine, the Office of the Associate  
Dean for Graduate Medical Education 
(GME) maintains oversight of accredita-
tion for all postgraduate clinical training. 
Once that piece of paper goes on the wall,  
residents and fellows go to work in varied 
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Fourth-year surgery resident Enjae Jung, MD, is actually in her sixth year of post-MD  training. Aer earning her medical degree  
at Washington University School of Medicine  
in 2006, she completed two years of residency,  
followed by two years conducting basic research.
According to Mary E. Klingensmith, MD, the 
Mary Culver Distinguished Professor of Surgery 
and director for the general surgical residency 
program, it is not uncommon among surgery  
residency programs for trainees to spend two 
years conducting dedicated postdoctoral research. 
is training builds a foundation for future  
academic research and funding; it also gives  
residents an edge when applying for competitive 
fellowship positions. 
Jung’s passion for surgery was ignited when 
she shadowed a surgeon as an undergraduate. She 
applied to medical school intent on specializing in 
surgery and has never wavered from that goal.
“I love the bond I share with my patients,” says 
Jung. “ere’s a lot of trust in allowing someone 
to operate on you, and there’s a lot of emotional 
investment when you’ve operated on someone.”
She credits the people who run, teach and 
participate in the surgery residency program at 
Washington University with making her experi-
ence so successful, and she notes that the GME 
office also plays an important role.
“e Department of Surgery leadership has put 
measures into place that maximize our learning 
while remaining compliant with ACGME restric-
tions, such as restriction of duty hours,” says Jung. 
Compliance with duty hours and maintenance 
of a quality educational environment for trainees 
is a primary focus for the GME office. According 
to Klingensmith, McAlister and Drake are readily  
available for advice and insight when daily chal-
lenges in running a resi-
dency program arise.
Jung plans to take 
advantage of an early 
specialization program, 
an opportunity offered 
for physicians interested 
in doing a fellowship in 
vascular surgery. As she 
completes her fih year of 
general surgery, she will 
begin a two-year fellowship 
in vascular surgery. 
 Other aspects of the program also support the 
transition from training to beginning a career.  
“e faculty are national leaders, yet they are 
approachable and interested in my education and 
training,” says Jung. “I also have great colleagues; 
my fellow residents are supportive, and we  
definitely look out for each other.” 
“The faculty are  
approachable and  
interested in my  
education and  
training.”  
 — Enjae Jung, MD
Outlook  13outlook.wustl.edu





























Enjae Jung, MD,  
in the OR.
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Amit Patel, MD, a second-year resident in   internal medicine and a 2010 graduate of the      School of Medicine, has a passion for research. 
While patient care remains his focus, he cur-
rently is participating in CSTAR (Clinical Science 
Training and Research), a residency training path-
way that allows for three months of uninterrupted, 
dedicated clinical research time.
“When you’re on clinical 
rotations, our demanding hours 
can make it difficult to partake 
in research,” says Patel. “CSTAR 
offers residents interested in 
clinical research the opportunity 
to learn how to prepare proposals 
and conduct research that will 
assist them in becoming suc-
cessful clinician-investigators.”
Like his research mentor,  
C. Prakash Gyawali, MD,  
professor of medicine, Patel 
plans to specialize in gastroenterology. e field 
includes an interesting array of procedures and 
emerging technologies, but will still allow Patel  
to build long-term relationships with his patients.
Patel also serves on the Washington University 
Institutional Review Board and is co-authoring 
several chapters in the Washington Manual 
Subspecialty Consult Series, and serves as a senior 
staff writer at iMedicalApps.com.
“We have a number of special programs, 
including career and research mentorship, train-
ing in how to conduct clinical research, training  
in quality improvement, and education in global 
health,” says Melvin S. Blanchard, MD, FACP, 
associate professor of medicine, chief of the 
Division of Medical Education, and director of  
the Internal Medicine Residency Program.
Programs like these are what make residency 
opportunities at Washington University School of 
Medicine unique. e educational oversight of the 
GME office ensures that every clinical program 
offered meets ACGME guidelines.
at’s a safeguard Patel appreciates.
“e GME staff does a terrific job,” he says. 
“ey stand ready to ensure that our education is 
both expansive and fair.”
Blanchard concurs, saying: “Dr. McAlister and 
Tia Drake are very responsive, efficient and enthu-
siastic. ey are very supportive of our educational 
programs and curriculum, and their oversight 
helps us facilitate the sharing of ideas across the  
82 training programs at Washington University.”
Even with protections in place, residency train-
ing remains a challenging and difficult endeavor.
“You have to love what you do,” says Patel. “No 
doubt residency can be exhausting at times, but if 
you love taking care of patients and making them 
feel better, you embrace its challenge and finish 
each day with a sense of fulfillment.”
”The GME staff does a  
terrific job. They stand 
ready to ensure that 
our education is both 
expansive and fair.”    
 — Amit Patel, MD
Combining interests
Amit Patel, MD, left, and 
Melvin S. Blanchard, MD, 
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Figuring out the etiology of a patient’s present-ing symptoms is what drew Sara W. Dyrstad, MD, to radiology, a specialty that requires 
careful study of anatomy and pathology using an 
array of imaging techniques and procedures.
Now in her fourth and final year of residency, 
Dyrstad plans to continue her training as a breast  
imaging fellow at the Center for Advanced Medicine 
at Washington University Medical Center. 
“Radiology is a fascinating, challenging field 
that allows me to have focused patient interaction 
and to communicate with clinicians from a variety 
of specialties,” says Dyrstad, who earned her med-
ical degree in 2007 at Southern Illinois University 
in Springfield, Ill. “No day is ever the same.”
 roughout residency training, Dyrstad has 
channeled her passion for problem-solving beyond 
medical issues to those that arise outside the 
imaging suite.
Representing the Missouri State Medical 
Association as a section delegate for the Resident 
and Fellow Section of the American Medical 
Association (AMA), she has been active in the 
national discourse about postgraduate education. 
“Sara’s involvement with the AMA underscores 
her commitment to radiology and the future of 
medicine,” says interventional radiologist Jennifer 
E. Gould, MD, assistant professor of radiology and 
diagnostic radiology residency program director. 
“at commitment, coupled with her level-headed 
approach to issues, made her an easy choice as a 
resident representative to the GME  
Consortium committee.” 
For the past year and a half, Dyrstad and  
three other postgraduate trainees have served  
on the committee, composed of GME and hospital 
administrators, residency and fellowship program 
directors, and residents and fellows. Most recently, 
they have focused on providing a peer forum for  
postgraduates to help 
address any possible  
concerns that may arise 
during their training.
“It’s great to be a con-
tributing member to the 
GMEC,” says Dyrstad. 
“Not only do we get to 
voice our concerns, we  
also gain insight into global 
issues that affect residency training, such as duty 
hour restrictions, and possible program changes.”
“Sara has been a delight to have as a resident,” 
says Gould. “She has matured over her four years 
of training to become a leader. Her ‘can-do’ atti-
tude and willingness to jump in and work hard 
make her a pleasure to have on service.”
 
“As contributing GMEC  
members, we get to 
voice our concerns.”  
 — Sara W. Dyrstad, MD
Sara W. Dyrstad, MD, left, and 
Jennifer E. Gould, MD, study 
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Behind-the-scenes 





B Y   J U L I A  E V A N G E L O U 
S T R A I T
T H E  P A S T  3 0  Y E A R S  has seen a revolution in the 
treatment of injuries to peripheral nerves. Arms and legs,  
hands and feet rely on peripheral nerves to function and feel,  
and a few surgical specialists across the country have devoted 
their careers to fixing these delicate white fibers when they  
are damaged or broken. And behind the scenes, informing all  
of this surgical work, is the laboratory. 
“Every question that comes up in the clinic, 
we have looked at in the laboratory,” says Susan 
E. Mackinnon, MD, the Shoenberg Professor and 
chief of the Division of Plastic and Reconstructive 
Surgery. “We bring the answers we discover in the 
lab back to the clinic and the operating room.”
Over three decades, this flow of information between 
laboratory, clinic and OR has led to huge shifts in the 
understanding of nerve injury and regeneration. Limbs that 
might once have been amputated can be saved: A patient’s  
own healthy nerves can be rerouted into a damaged limb,  
and nerves from a cadaver can be transplanted while  
minimizing risk of rejection. 
A major figure in this work is Daniel A. Hunter, senior  
scientist in Mackinnon’s lab and an expert in the microscopic 
analysis of nerves. Mackinnon calls Hunter’s work an integral 
part of her surgical practice. 
“Dan has devoted his life to quantifying nerve regeneration 
and developed his own unique techniques to measure what  
we see under the microscope,” Mackinnon says. “He can make 
the visual images of nerves — and they’re beautiful images 
— into actual numerical results. So you can compare different 
strategies for treating nerve injury in a very scientific way.”
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Imaging techniques developed by Dan Hunter and colleagues 
in the peripheral nerve lab set a standard for quantitative 
analysis of regeneration. Hunter modified computer software 
to augment the painstaking application of his lifetime of 
research experience. Above and below: Examples show how 
raw images are progressively refined to yield valuable data.
ROBERT BOSTON
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Neural pathways
Exacting peripheral nerve studies  
                      inform breakthrough             
                      surgical procedures
The peripheral nervous system 
sends neural impulses to and from 
the brain, directing the body as 
it interacts with its environment. 
Injuries can impair or sever these 
vital links. But research shows that 
this system can be re-engineered  
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Neural pathways
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Ulnar nerve damaged  
in upper arm
Slices float 










Assessing nerve regeneration 
experiments requires human 
and computer prowess in a 
painstaking, multistage effort 
that results in quantified data.
Viable nerve fibers mapped
Mathematical analyses of  








If a human hair  
were this size. . .
a slice of nerve cut with 
an ultramicrotome 
would be about this size 
(red line).
Processing to clarify the image
Applying false color to label 
each fiber and its myelin sheath
Separating the components  
for computer analysis
The surgeon plugs a non-critical nerve into an 
injured nerve; at the microscopic level, new 
connectivity begins forming (elongated fibers, 
left). With therapy, the patient can regain 
elaborate neuromuscular functions  
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On Hunter’s first day working for Alan Hudson, MB ChB, 
who later became neurosurgeon-in-chief at St. Michael’s 
Hospital in Toronto, the windowless basement lab had a 
rotary telephone, a typewriter, an old surgical microscope, 
and an ultramicrotome, a device used to slice impossibly 
thin sections of biological samples to look at under micro-
scopes. It was 1973. 
“Dr. Hudson handed me a box of rat nerves,” Hunter 
recalls. “I asked what I should do with it, and he said, ‘You 
figure it out; I’m going on vacation.’ And he le. at was like 
baptism by fire. I think it was a test to see what I could do.”
In 1978, as a plastic surgery resident at the University 
of Toronto with an interest in nerve injury, Mackinnon 
sought out the Hudson lab. ere, she and Hunter used ani-
mal models to do the first studies of immune response and 
rejection in transplanted nerve, paving the way for the first 
human nerve transplant, performed by Mackinnon in 1988. 
Today at Washington 
University, 38 years aer his 
first days in the lab, Hunter 
still works in a window-
less room. Rotary phones 
and typewriters have made 
way for computers and cell 
phones. But the ultrami-
crotome, transplanted from 
Toronto, remains.
Since this particular 
ultramicrotome is no longer 
manufactured, Hunter does 
any required maintenance 
himself. Perhaps reminiscent of the transplanted nerves he 
examines, he harvests replacement parts from his stash of 
secondhand ultramicrotomes of the same make and model. 
Though modern ultramicrotomes use diamond knives, 
Hunter prefers the instruments and methods he perfected 
early in his career. “I’m old school,” Hunter says with a laugh. 
“If I had to switch instruments, I think I would just leave.”
e glass knives he makes himself are sharper than  
diamond, but more fragile. Aer only a handful of cuts, 
the edge dulls and the knife must be replaced. Neat rows of 
triangular glass knives sit on Hunter’s bench top, waiting to 
be mounted in the ultramicrotome to slice cross sections of 
nerves embedded in a hard epoxy resin.
A microtome is termed “ultra” when it cuts samples even 
thinner than the already thin sections cut by regular micro-
tomes. With his vintage ultramicrotome, Hunter can cut 
sections as thin as 60 nanometers. at’s 1,000 times thinner 
than a human hair. Indeed, the sections are so thin they can-
not be handled directly, but are collected on the surface of a 
tiny pool of water flush with the glass cutting edge. Floating 
on the water’s surface, the sections appear in vibrant colors 
— tiny postage stamps of shimmering blues, greens, or  
purples depending on their thickness. e same complex 
optical physics is at work in the rainbow of colors seen in 
thin films of oil floating on street puddles. 
Hunter scoops these samples up with a platinum wire 
loop and mounts them on glass slides for light microscopy or 
on metal grids for the extreme close-up view provided by an 
electron microscope. 
In the images of nerve cross sections, the average person 
sees wiggly lines, circles with thick borders, circles with thin 
borders, dots and splotches of all shapes and sizes. But to 
Hunter, each nerve section tells a story.
“is is a crush injury,” he says, pointing to the small 
circles in one of the images.
When a nerve is crushed, the layer of insulation sur-
rounding the nerve fibers, called myelin, gets thinner. But 
the axon, the “wire” that transmits electrical signals, stays 
the same. As the myelin sheath thins, the axon’s electrical 
signals slow down. 
“is axon here is dying,” he explains. “It’s being torn 
away from the myelin. Some scientists may not count these 
accurately because they can’t distinguish between viable and 
nonviable axons.”
Originally, Hunter counted axons and examined nerve 
sections entirely by hand. Seeking to speed up his process, he 
found help from an unlikely source: He co-opted an imaging 
system intended for examining metals — iron, steel, alloys 
and ores — and wrote his own programs to make the system 
analyze nerve cross sections instead. 
“I don’t even know how he came up with that,” says 
Mackinnon. “But for every new operation that I develop,  
Dan looks at the nerve regeneration in animal models first 
and tells me whether the new technique worked.”
Hunter’s methods have proven so comprehensive that 
researchers at other universities have purchased the metal-
lurgy soware platform to use with his custom peripheral 
nerve programs. Groups at the University of Pittsburgh, 
Massachusetts General Hospital, the University of Texas 
Southwestern Medical Center at Dallas, and Chang Gung 
Memorial Hospital in Taiwan are now using Hunter’s system 
in their own nerve investigations.
“Dan has been doing this type of analysis on nerves his 
entire career,” Mackinnon says. “He has really focused on 
that with tremendous intellect and passion and become 
extraordinarily expert in it.”
Hunter calls these meticulous methods the gold standard 
in quantifying the state of a nerve, whether healthy, injured 
or regenerating. 
“It gives us far more information than any other tool to 
assess nerve regeneration,” he says. “Other groups might 
choose to only count axons. And I’m not saying that’s right 
or wrong. We are just extremely comprehensive when we 
look at nerve injury and regeneration. at’s one aspect of 
our lab that sets us apart.”
Surgeries use nerve regeneration  
techniques first verified by imaging  
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IN ONE WAY OR ANOTHER, nearly everyone at the  
School of Medicine has heard of Bernard Becker, MD.
Many use the beautiful Bernard Becker Medical Library or 
consult rare eye books there from the well-known Becker 
collection. In the Department of Ophthalmology, which  
Becker chaired for more than 35 years, faculty members  
know well his landmark research on glaucoma. One member, 
David C. Beebe, PhD, is the Janet and Bernard Becker  
Professor of Ophthalmology and Visual Sciences.  
But Becker is much more than a portrait in the library.
B Y  C A N D A C E  O ’ C O N N O R
The remarkable life of a celebrated  
         clinician /mentor /scientist /citizen
In this portrait, Bernard 
Becker, MD, holds the first 
comprehensive text on eye 
diseases and treatments, a 
rare 16th-century book from 
the extensive collection of 
ophthalmology texts that 
he donated to the School 
of Medicine's library, later 
named in his honor.
Outlook  21outlook.wustl.edu
      Becker’s  
(re)collection(s)
114503_Becker_21-23_CS5.indd  21 12/13/11  5:06 PM
22  Washington University School of Medicine
Accepted leadership 
of ophthalmology 
department in 1953 at 
age 33, becoming the 
university’s youngest 
chairman; served for  
35 years His 500 publications 






Taught and inspired 
legions of students
At 91, Becker is still a vital force in the lives of his former 
colleagues and residents, some 18 of whom went on to head 
ophthalmology departments of their own. ough wheel-
chair-bound from hip and vertebrae fractures, he is still 
highly alert and active on the computer, reading journals 
and sending articles to colleagues around the world.
“It’s a compulsion of mine. When I read an article, the 
first thing that occurs to me is: ‘My gosh, this is something 
so-and-so needs to know about,’” says Becker.
According to Michael A. Kass, MD, the Bernard 
Becker Professor and current head of the Department of 
Ophthalmology and Visual Sciences, Becker’s greatest legacy 
is the people he trained and continues to influence. “He 
inspired us to pursue excellence, question dogma, and seek 
answers to important basic and clinical questions,” says Kass.
And Becker is still winning awards, though he modestly  
downplays them. e American Academy of Ophthalmology 
honored him with its prestigious Laureate Recognition 
Award in 2009. From the Association for Research in Vision 
and Ophthalmology (ARVO), an organization he was instru-
mental in founding, Becker has received the Proctor Medal, 
the Friedenwald Award and the Mildred Weisenfeld Award.  
But another legacy, and one that Becker values equally, 
is the work that he and his wife, Janet, have done to further 
social justice. He still uses his contacts to raise money for 
causes such as combatting homelessness, feeding the hungry, 
housing ex-offenders and offering scholarships to students.
“My wife and I were brought up Jewish, and we both faced 
discrimination,” he says of his commitment. “I was also 
brought up to like people no matter what their religion.”
Childhood and Education
Growing up in Brooklyn, Becker was early, and excellent, 
at everything he attempted. As soon as he started school, 
he was promoted to third grade — and from then on was 
younger than everyone in his classes. Aer high school, he 
won a scholarship to Princeton University, where he was one 
of six Jewish students in a class of 400. He tutored wealthy 
young men to supplement his budget.
At Princeton, Becker became a chemistry major and 
worked with the head of the department, H.S. Taylor, PhD, 
in researching the structure of molecules, especially pro-
teins and polypeptides. Taylor wanted him to continue on 
for a PhD in chemistry, but Becker felt that medical train-
ing would allow him to apply his research. So he went to 
Harvard Medical School on a scholarship and worked in the 
laboratory of A. Baird Hastings, PhD, head of biochemistry.  
With World War II under way, Becker finished medical 
school and his internship on a truncated schedule and  
served in the military.
 Aerward, he might have stayed in biochemistry if not 
for a fortuitous meeting with Jonas S. Friedenwald, MD,  
a renowned histochemist at Johns Hopkins University. 
Friedenwald had a dazzling intellect, and when he invited 
Becker to Hopkins for his residency, Becker eagerly 
agreed. But he didn’t fully realize that ophthalmology was 
Friedenwald’s primary interest — and thus Becker began his 
migration toward eye research.
“at was an exciting time,” says Becker. “Friedenwald 
was a brilliant man, who even knew all about legal things —  
all about everything. When they needed advice on the  
Looking back on the storied career of a  
clinical scientist, a “jack-of-all-trades”  
BERNARD BECKER, MD
Military service in World War II
ADAPTED FROM A PRESENTATION BY GEORGE M. BOHIGIAN, MD
Winter 2011
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the country to convince medical schools they should estab-
lish full-time ophthalmology departments with NIH funds.  
Horrified by the segregation that he found in McMillan 
Hospital, he adamantly insisted that it be integrated, and he 
also appointed African Americans to the staff, among them 
Howard P. Venable, MD. At the same time, Janet Becker was 
working in the community, forming organizations such as 
Beyond Housing.
“In those days, every floor in the hospital had cigarette 
machines — and this was the institution that had established 
the link between smoking and lung cancer!” says Becker.  
“I was a rebel, and I insisted they take the machines off the 
floors. e only one who would support me was Carl Moyer, 
head of surgery, because there was so much money to be 
made from them.”
He also managed to continue his own research, amassing 
some 500 publications and writing a well-known textbook, 
Diagnosis and erapy of the Glaucomas, still in use today. 
Altogether he served for 35 years as department chair, step-
ping down in 1988. Next he took on the project of remaking 
the inadequate library, later named for him in recognition of 
his work. For years he had been buying precious eye texts, and 
he donated the entire 600-volume collection to the archives.  
Among his and Janet’s five living children, one is also 
an ophthalmologist — William L. Becker, MD 87 — while 
the other four sons include a teacher, artist, musician and 
crasman. e couple also has 10 grandchildren. But Becker 
has other “children,” too, he says. “Teaching people to do 
research and take care of patients spreads your ability to do 
good. And that carries over.”
U.S. Supreme Court, they called on him; in fact, Justice Felix 
Frankfurter used to come to the lab to visit with Friedenwald 
and talk about issues coming up before the Court.”
During the five years that he spent at Hopkins, Becker 
developed methods for diagnosing glaucoma and measuring  
aqueous humor, directed the residency program, did non-
stop research and served as chief resident. At age 30, he 
celebrated one of his happiest accomplishments: marrying 
his wife, Janet, a Philadelphia-born Sarah Lawrence graduate 
deeply committed to civil rights.
The Washington University Years
Before his marriage, Becker roomed with fellow ophthal-
mology resident Lawrence Post Jr., MD, son of the part-
time ophthalmology chairman at Washington University, 
Lawrence Post Sr., MD. Word got back to the School of 
Medicine about Becker, and at the end of his third residency 
year, Dean Robert A. Moore, MD, recruited him to head the 
Department of Ophthalmology, but Becker refused. When 
Moore tried again two years later, Becker accepted. At age 33, 
he was the university’s youngest department chairman.
Arriving in St. Louis in 1953, Becker faced some  
immediate challenges, among them building up the resi-
dency program, creating a strong research focus, hiring new  
faculty and forging a solid relationship with community 
physicians. At the same time, he took on important national 
roles: founding ARVO, serving as first editor-in-chief of 
Investigative Ophthalmology & Visual Science, and traveling  
Founded Association  




Built Association for 
Research in Vision and 
Ophthalmology (ARVO)      
Directed 
American Board of 
Ophthalmology
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With his wife, Janet, 
championed the poor, 
the homeless, the 
disenfranchised




of rare eye texts
Attending Grand Rounds
The Becker Collection of books, 
manuscripts and graphics, housed 
in the Becker Library's Archives and 
Rare Books, includes many rare items 
chronicling the parallel evolution of 
ophthalmology and scientific optics.
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called into a room where a man in a white coat  
holds up charts next to your face to look at your  
eye color and uses tools to measure the bridge of 
your nose, width of your forehead and circum-
ference of your head. 
Hundreds of thousands of children and adults 
were measured this way by physicians, who also 
recorded family genealogies to trace 
hereditary traits. e practice was  
part of a broad effort using German 
physicians and others to racially 
“cleanse” European society of people 
seen as biologically inferior and  
those perceived as racial enemies of 
the German people.
is practice of the “science” of 
eugenics, or racial hygiene, as it 
was known in Germany, is featured 
in “Deadly Medicine: Creating the 
Master Race,” a traveling exhibition 
from the United States Holocaust 
Memorial Museum recently on display at the School 
of Medicine’s Bernard Becker Medical Library.  
e exhibit highlights the role of science and  
medicine in the Holocaust. 
Medicine
GONE WRONG
MAGINE BEING A CHILD IN 1930s GERMANY,
Exhibit shows how a cloak of spurious 
health claims once hid a deadly agenda
I
Sign of the times: A British poster from 
the early 1930s promotes the surgical 
sterilization of genetic “inferiors.”
“Our starting point is not the individual, 
and we do not subscribe to the view 
that one should feed the hungry, give 
drink to the thirsty, or clothe the naked.    
 . . . Our objectives are entirely different: 
We must have a healthy people in order 
to prevail in the world.”
 — Joseph Goebbels,  
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“‘Deadly Medicine’ helps us understand how 
our contemporary world came to be and the 
human stakes involved in trying to improve  
the human race,” says Stephen S. Lefrak, MD,  
professor of medicine and assistant dean of the 
Humanities Program in Medicine. “If history 
teaches us anything, it is that what has hap-
pened, can in fact happen. It certainly behooves 
an engaged citizen to comprehend that National 
Socialist Germany was a biological state that 
sought humankind’s perfection through racial 
and biological selection. erefore, for medicine in 
the age of genomics, in vitro fertilization and the 
search for wonder cures, the exhibit is a striking 
billboard warning us to be wary of the promise of 
biological utopian fantasies.”
Robert W. Sussman, PhD, professor of anthro-
pology in Arts & Sciences, says the exhibit pres-
ents many historical events and ideas that aren’t  
commonly known.
“In many cases, 
people don’t realize 
how medicine and 
science can be used  
in such a very bad 
way,” Sussman says. 
“People have forgot-
ten how horrible 
those things that 
occurred during  
World War II were.  
e ‘Deadly Medicine’ exhibit shows very well 
the connection between medical scientists and 
anthropologists and how the American eugenics 
movement influenced the Nazis.”
Sussman says many of the ideas presented in 
the exhibit about different races are still an under-
current in the United States today. 
“is exhibit really shows how people can  
think so differently, how the behaviors we think 
are atrocious can be really part of their culture.”
In the 1930s, the National Socialist (Nazi) party 
enacted a law preventing “genetically diseased off-
spring” by a mass sterilization program. is emu-
lated sterilization laws enacted decades earlier in 
the United States and the Scandinavian countries. 
More than 400,000 German citizens were sterilized 
over the next 13 years for hereditary conditions 
including schizophrenia, manic-depressive disor-
der, genetic epilepsy, genetic blindness or deafness, 
and severe physical deformity, among others. 
Midwives and physicians were enlisted to regis-
ter all children born with severe birth defects and, 
during World War II, 
the program was 
expanded to include 
children and adults 
deemed “incurable.”  
ey were sent to 
specialized hospital  
centers, where they 
were then gassed or 
starved to death. e 
Nazis justified these 
as “mercy deaths,” 
using asylum direc-
tors, physicians and 
nurses to end “lives 
unworthy of life” for the good of the Fatherland. 
In 1942, the “euthanasia” program and its med-
ical personnel were moved to German-occupied 
Poland. ere, in camps specially constructed as 
killing centers, gas chambers were used to murder 
millions. It was to these death camps that 6 million 
Jews and hundreds of thousands of Romany were 
transported from throughout Europe and killed in 
a policy of total extermination (“the final solution”).
B Y  B E T H  M I L L E R
Hartheim “euthanasia” center  
staff enjoying leisure time,  
circa 1940–42
Choosing a Mate 
(excerpts)
Remember that you are a 
German. Everything you are 
is not of your own merit but 
through your nation.
If you are hereditarily 
healthy, you should not 
remain unmarried.
As a German choose only 
a spouse of the same or 
Nordic blood. The mixing of 
races that do not match each 
other  . . . frequently leads to 
degeneration and downfall in 
the life of people and nations.  
Seek a companion in mar-
riage and not a playmate. 
The purpose of marriage is 
having children and raising 
descendants. Only among 
mentally, physically and racially 
homogenous people can this 
ultimate goal be achieved.
“Ten Commandments for Choosing 
a Mate,” created by the Reich 
Committee for Public Health.  
From the pamphlet May I Marry  
My Cousin? [1935]
“Don’t Go Blindly Into 
Marriage!” In 1926, officials 
in Berlin opened the first 
eugenics bureau that certi-
fied fitness for marriage.
Based on an exhibit that opened at the U.S. Holocaust 
Memorial Museum in Washington, D.C., in April 2004.  
Visit ushmm.org/deadlymedicine
Dr. Friedrich Mennecke and his 
wife, Eva, served Operation 14f13, 
which expanded gassings to  
concentration camp inmates too 
sick to work and, more broadly,  
to Jewish prisoners.
Jews as “microbes” and 
Bolsheviks as “germs,” 
from Nazi journal  
Der Stürmer (The 
Attacker), 1943
Nazi killing centers where millions perished: Jews, Gypsies,  
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Alumni endowed professorships support full range of faculty efforts
B Y  D I A N E  D U K E  W I L L I A M Sexceptional faculty
Mission forward 
For clinician Alan C. Braverman, MD,  having an endowed professorship is a  tremendous honor.
“I am very grateful to the alumni for this profes-
sorship,” says Braverman, the Alumni Endowed 
Professor of Cardiovascular Diseases. “Washington 
University is an incredible research facility, and 
we also want to be known for providing excellent 
clinical care. When we give these professorships to 
clinicians, it highlights the mission of the medical 








Alan C. Braverman, MD, 
with cardiology patient 
Thomas Stobbs.
 In addition to his clinical practice, which covers 
all aspects of noninvasive cardiology, Braverman is 
a nationally known authority on genetically trig-
gered aortic diseases such as Marfan syndrome and 
thoracic aortic aneurysms and dissections.
Braverman’s professorship helps him conduct 
clinical research projects on aortic dissections and 
aneurysms that would not have been possible other- 
wise. It also provides support for the Washington 
University Marfan Syndrome and Genetically 
Triggered oracic Aortic Aneurysm Clinic.
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 “Over the years, the impact of the salary support  
provided by the professorship has moved my laboratory’s 
research in new directions and has allowed us to pursue new 
initiatives as opportunities presented themselves, rapidly 
broadening the scope and impact of our work,” she says.
She adds that a clear case in point is the recent establish-
ment of the Translational Cardiovascular Tissue Core at 
Washington University, a multi-investigator, collaborative 
effort that Nerbonne is leading with additional seed fund-
ing from the Institute for Clinical and Translation Sciences 
(ICTS) and the Children’s Discovery Institute.
Such initiatives are what keep Washington University 
School of Medicine at the forefront of medical science and 
patient care. Alumni Endowed Professorship are just one  
of many ways to show support for the school’s mission.
B Y  D I A N E  D U K E  W I L L I A M S
Endowed professorships help to attract and retain excep-
tional faculty like Braverman, and these professorships are 
among the highest honors that a university can bestow on  
its researchers, clinicians and teachers.
In 1978, the Alumni Endowed Professorship program  
was established with the goal of creating one professorship 
in each department of the School of Medicine. e profes-
sorships are funded by unrestricted gis of $1,000 and 
greater from medical alumni and former house staff.
To date, the program has funded nine professorships. 
e first Alumni Endowed Professorship at the School of 
Medicine, established in 1982, was held by Philip Needleman, 
PhD, in the Department of Pharmacology.  
e first endowed professorships, supported by private 
philanthropy, were established at the School of Medicine in 
1910. To date, 159 professorships, including alumni endowed, 
have been created. ese professorships have helped propel 
the medical school into the world-renowned institution it 
has become.
With endowed professorships, the income from perma-
nently invested funds provides salary, benefits and research 
support. Endowed professorships guarantee a stream of 
funding that helps to offset the vagaries of external research 
funding, which oen enables researchers to pursue projects 
at the frontiers of current knowledge and understanding. 
An endowed professorship continues as long as the  
university endures, representing a commitment to support 
and sustain the advancement of the medical school.
It was an incredible honor to receive the Alumni Endowed 
Professorship in Molecular Biology and Pharmacology in 
2001, says Jeanne M. Nerbonne, PhD. She admits, however, 
that at the time she had little idea of what that honor would 
mean in practical terms.















Dora E. Angelaki, PhD
Anatomy and Neurobiology
Douglas E. Berg, PhD
Molecular Microbiology
Alan C. Braverman, MD
Cardiovascular Diseases
Elliot L. Elson, PhD
Biochemistry and Molecular 
Biophysics 
Robert P. Mecham, PhD
Cell Biology and Physiology
Jeanne M. Nerbonne, PhD
Molecular Biology and 
Pharmacology
David M. Ornitz, MD, PhD
Molecular Biology and 
Pharmacology
Robert D. Schreiber, PhD
Pathology and Immunology
Alumni Endowed Professorships
Through the work of faculty 
such as Braverman and Jeanne 
M. Nerbonne, PhD, Alumni 
Endowed Professor of Molecular 
Biology and Pharmacology, left, 
new knowledge is created and  
the next generation of physi-
cians and scientists is trained.
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George M. 
Bohigian, MD
James W.  
Seeser, PhD, and 
his wife, Judy
History of medicine useful in guiding the future
Support to train audiologists and therapists
George M. Bohigian, MD, professor of clinical  ophthalmology and visual 
sciences, knows the importance of 
connecting with others.
He began his career as a high 
school science teacher after earning 
an undergraduate degree (LA 61, 
zoology) and a teaching certificate 
from Washington University. He 
soon realized he wanted to make 
an even bigger difference, which 
brought him to medical school and 
then Washington University School 
of Medicine for his residency.
During his residency, Bohigian 
was inspired by the chairman of the 
Department of Ophthalmology and 
Visual Sciences, Bernard Becker, MD. 
“Dr. Becker is one of the most 
brilliant people I have ever met,” 
says Bohigian. “He taught me how 
to think critically and encouraged 
the residents to do good research.”
Becker also had an impact 
on Bohigian’s future interests. It 
was Becker who first urged him 
to present a paper at the Cogan 
Ophthalmic History Society; today,  
Bohigian serves as its president.
The study of history not only 
gives him an appreciation of the 
past and present, but also serves 
as a guide to the future, says 
Bohigian. He finds this knowledge 
helpful when treating his patients.
Bohigian describes one of his 
life’s purposes — teaching — as 
“being able to share your light and 
knowledge with those around you.” 
Bohigian’s connection to the 
university continues to shine. 
He and his wife, Chris, have 
recently established the Bohigian 
Lectureship in Ophthalmic History 
and Visual Sciences.
They know that philanthropy 
strengthens both the university 
and the St. Louis community. 
“We are pleased to support 
Washington University School of 
Medicine and to emphasize the 
importance of history,” says George 
Bohigian.  “The newly formed 
Center for History of Medicine at 
the medical center should be a 
valuable addition to this endeavor.” 
Growing up with deaf par-ents put James W. Seeser, PhD, in an unusual role. 
As the oldest child in his family, 
Seeser served as an interpreter for 
his parents, landing him squarely 
in the adult world. He remembers 
negotiating a car purchase with his 
father when he was just 6 years old.
Still, he never truly felt he could 
bridge the gap. “Being deaf in a 
hearing world, my parents lived 
in a parallel universe,” says Seeser.  
“Being unable to fully communi-
cate is a huge barrier.”
Those early lessons taught him 
self-reliance and left him deter-
mined to figure things out for 
himself, a trait he carried into his 
chosen field of science.  
From his parents, Seeser gained 
strong ethics and morals. He also 
learned about giving back and has 
used that knowledge to become 
personally involved in helping 
other families that are affected by 
hearing issues.
Realizing that educating  
future audiologists and therapists  
is crucial to helping hearing-
impaired children, Seeser donates 
annually to support scholar-
ships established in Washington 
University School of Medicine’s 
Program in Audiology and 
Communication Sciences (PACS).
 “Jim Seeser has been an impor-
tant friend and supporter for the 
PACS programs for a number of 
years,” says William W. Clark, PhD, 
professor of otolaryngology and 
director of PACS. “His passion and 
motivation stem from his personal 
experience as the child of deaf 
parents; his experience as a fellow 
academician and research scientist 
make him a valuable colleague and 
consultant to our programs.”
Seeser credits Jerome R. “Jerry” 
Cox Jr., ScD, senior professor in 
computer science, with his involve-
ment in the PACS program at 
Washington University. Through 
Cox and Clark, he has learned the 
importance of data gathering and 
sharing information with parents  
as they make decisions for their 
hearing-impaired children.  
Early diagnosis and the use 
of hearing technologies such as 
cochlear implants and digital hear-
ing aids provide the opportunity 
for hearing-impaired children to 
maximize their ability to function in 
the hearing world.
“Jim Seeser’s vision, business 
experience and entrepreneurship 
are valuable resources, and his 
financial support helps us achieve 
the goals we share,” says Clark. “We 
want to attract and train the most 
highly qualified leaders in the field.”
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2nd Century awardees  
honored at annual banquet
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2011 2nd Century Award recipients, from left:  
Robert G. Clark, Morton E. Smith, MD, and Timothy J. Ley, MD 
e 2011 2nd Century Awards were presented at a dinner 
held at the Ritz-Carlton Hotel in Clayton on September 16.  
e awards recognize those whose long-term commitment  
and participation have truly made a difference and whose 
ongoing support allows the School of Medicine to move  
forward in its second century with strength and confidence. 
Robert G. Clark is the chairman and CEO of Clayco, a 
firm specializing in real estate development, engineering, 
architecture and construction in industrial, corporate, insti-
tutional and residential markets. Clark and his late wife, 
Ellen, dedicated their time and resources to a broad range 
of critical issues. e Clark family recently made a gi to 
Washington University School of Medicine to build and 
dedicate the Ellen S. Clark Hope Plaza to the school.
Timothy J. Ley, MD, the Lewis T. and Rosalind B. Apple 
Professor of Medicine, is a hematologist, oncologist and  
cancer biologist. He is an internationally known expert 
in the pathogenesis of acute myeloid leukemia (AML) and 





Michael Crowder, MD/PhD 89
Kevin T. Baumgartner
Bradley A. Evanoff, MD 86, HS 89
Justin D. Krogue
Stanley M. Wald, MD 46
Austin J. Wesevich
Naomi Y. Jiang
Laura J. Bierut, MD 87, HS 91
The Distinguished Alumni Scholarship 
Program awards four-year, full-tuition 
scholarships named in honor of 
esteemed alumni of the School of 
Medicine. Honorees are selected based 
on outstanding citizenship and leader-
ship, and scholars are chosen for their 
exceptional academic record and char-
acter. In addition to these four students, 
there are 86 others that receive funding 
in part through unrestricted gifts to the 
Annual Fund.
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was the first to use the reference sequence of the human 
genome to systematically identify the mutations responsible 
for the initiation and progression of cancer, focusing pri-
marily on AML. In addition, his laboratory was the first to 
develop an accurate mouse model of AML and the first to 
sequence a mouse cancer genome.
Morton E. Smith, MD, professor emeritus of ophthalmol-
ogy and visual sciences and associate dean emeritus for post-
graduate education, began teaching students at the School of 
Medicine in 1967. Now in his fih decade with the university, 
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memorial 
One person can make a difference in the world. Some people 
accomplish this through their work, some through their personal 
relationships, and some through their commitment to the commu-
nity. Joseph C. “Bo” Koster, PhD, managed to make a difference in 
each of those aspects through his life’s work advancing medicine.  
A St. Louis native, avid runner and bird watcher, Koster began 
working in the Department of Cell Biology and Physiology at 
Washington University School of Medicine as a graduate student. 
He turned down postdoctoral opportunities on the West Coast 
in order to stay within the department and work with Colin G. 
Nichols, PhD, the Carl F. Cori Professor.
Koster loved everything about science and being in the lab; his 
work set a high standard. In his later research, he discovered one 
of the fundamental causes of neonatal diabetes, a discovery that 
led to a revolution in therapy, allowing many patients to switch 
their therapy from insulin shots to pills.
His findings made a difference in the lives of many.
Sadly, he passed away in February, 2010. His important research 
findings remain alive in the work of his research partner Nichols 
as he continues their groundbreaking work.
“Bo was an important member of our departmental commu-
nity,” says Philip D. Stahl, PhD, professor emeritus and former 
head of the Department of Cell Biology and Physiology. “He was 
deeply and passionately engaged in his research and made the lab 
his second home. He is missed.”
Koster’s life pursuit was medical research; his devotion to 
this field led his uncle, Col. Charles R. Stribling III and his wife, 
Winnie Runge-Stribling, to establish an endowed fund in their 
nephew’s name. e Joseph C. Koster Memorial Fund has become 
a lasting tribute to him, and it inspires other researchers to make 
their own life-changing contributions to medical research.  
Koster’s important work continues to be a focus for Nichols’ lab. 
His family, brother R. Stribling Koster and sister Ann Antoniou, 
hope that the medical discoveries initiated by their brother will 
lead to better treatments for patients. Although Joseph C. “Bo” 
Koster is no longer with us, he continues to make a difference in 
the lives around us.
The Joseph C. Koster 
Memorial Fund has helped 
support activities associated 
with an annual Koster Memorial 
Lecture, presented by the Center for the 
Investigation of Membrane Excitability 
Diseases (CIMED) and the Department of 
Cell Biology and Physiology. The lecture 
series showcases the significant contribu-
tions to the understanding of membrane 
excitability and associated diseases.
The 2011 lecture featured Harvard 
Medical School neurobiologist Gary Yellen, 
PhD, who led a seminar titled “Reverse 
Engineering Epilepsy Therapy: Exploring 
Metabolism and Excitability.” The first  
two lectures were met with great  
success, an indicator that future  
lectures will be highly anticipated. 
“Bo” Koster’s love of science 
inspires contributions of others
Scientific 
spirit soars
B Y  M I C H E L E  H O E F T
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Ongoing support
Farrell Family Research Fund to focus  
on Alzheimer’s disease and dementia
David C. and Betty Farrell are close friends of Washington University  School of Medicine and have shown 
their confidence and trust in the university in 
myriad ways. Shortly aer moving to St. Louis 
in 1975 as president of May Department Stores 
Co., Farrell and his wife spent time immersing 
themselves in their local community. rough 
(then-Chancellor) William H. Danforth, MD, 
David Farrell became involved with Washington 
University, eventually becoming a university 
trustee. Since then, he has watched the university’s 
extraordinary growth and excellence in research 
for nearly four decades.  
e Farrell’s trust and personal belief in the 
university were made known early on when they 
endorsed the decision of both of their sons — 
Mark, LW 86, and David, LW 90 — to attend 
the School of Law. As the years progressed, 
their passion for the School of Medicine led 
them to give remarkable gis. When Farrell 
retired as chairman and chief executive officer 
of May Co., the couple, along with his former 
employer, established the David C. and Betty 
Farrell Distinguished Professorship in Medicine. 
In 2005, through a lead naming gi, the Farrells 
helped open the doors to the Farrell Learning and 
Teaching Center (FLTC). e outstanding educa-
tional facility for medical students and faculty has 
become a model for other institutions.
“With the opening of the Farrell Learning and 
Teaching Center, the university took an exciting 
B Y  M I C H E L E  H O E F T
step forward in providing world-class medical 
education,” says Larry J. Shapiro, MD, executive 
vice chancellor for medical affairs and dean of the 
School of Medicine. Today, the FLTC is the heart 
and hub of the medical center, training and edu-
cating the best and brightest students in the world. 
e Farrells’ support of the university hasn’t 
slowed. Most recently, they have contributed to  
the growth of the School of Medicine through  
a $1 million gi to establish and endow the  
Farrell Family Research Fund in the Department 
of Neurology.
Not only will this endowed fund support 
much-needed research in neurological disorders, 
specifically Alzheimer’s disease and dementia, it 
also will allow the School of Medicine to receive 
an equal amount from the Danforth Foundation 
for the Donald Danforth, Jr. Advanced Research 
in Neurological Disorders Endowment Fund, 
through the Danforth Foundation Challenge for 
Neurological Disorders.  
e Danforth Foundation Challenge was estab-
lished with a gi from the Danforth Foundation to 
support innovative research at the internationally 
known Hope Center for Neurological Disorders.
Gis like the Farrells’ that are received or 
committed by December 31, 2013 — up to a total 
of $10 million — will secure an equal amount 
of endowment support from the Danforth 
Foundation to support the Hope Center.  
e Farrells felt it was important that they  
contribute now. “Alzheimer’s disease has affected 
my family, so I have a special interest in it,” says 
David Farrell. “I’ve gotten to know Dr. John 
Morris and his work in the field. e medical  
school is without peers, and its partner,  
BJC HealthCare, is an outstanding institution.”  
e School of Medicine is honored to have 
the dedicated support of two of St. Louis’ most 
respected leaders, philanthropists and volunteers,  
David C. and Betty Farrell.
David C. and Betty Farrell
Gifts like the Farrells’ 
that are received or 
committed by December 
31, 2013 — up to a total 
of $10 million — will 
secure an equal amount 
of endowment support  
from the Danforth 
Foundation to support 
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scholarships
Leading  
   the way
Physicians committed to helping medical students finance their education
As co-chairs of the scholarship initiative committee and major donors to 
Washington University School of Medicine, Jay A. Kaiser, MD 72, and 
Gordon W. Philpott, MD 61, are as serious about attracting the best and 
brightest talent to the school as they are about helping medical students  
fulfill their dreams without the burden of enormous debt.
e two physicians, who both serve on the school’s National Council,  
share a commitment to today’s medical students and their chosen profession.
Kyle G. Jacobsen, Class of 2014, center, with Ronnie and Jay A. Kaiser, MD 72
Scholarships make education 
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Jay A. Kaiser, MD 72: A need to give back
Kaiser founded and is president of California 
Advanced Imaging Medical Associates located in 
the San Francisco Bay area.
But Kaiser, who remembers being a student 
fresh out of college who needed a leg up, came 
from much humbler beginnings.
“My father was a coal miner. I had no money,” 
he recalls. “To attend a medical school the qual-
ity of Washington University School of Medicine 
wouldn’t have been possible without scholarships 
and loans.”
 Kaiser credits his professional success not only 
to his medical education, but also to the culture of 
excellence and constant learning that he internal-
ized during his training in St. Louis.
“Everything I’ve achieved is due to the educa-
tion I received at Washington University,” he says.
Because of that, Kaiser and his wife, Ronnie, 
began donating to the university when he entered 
private practice. ey have a named endowed 
scholarship and contribute to the Class of 1972 
scholarship fund.
“It’s important that people from all economic  
levels of our society have the opportunity to attend 
medical school,” he says. “Who better to under-
stand that than physicians?”
Gordon W. Philpott, MD 61: The fun of giving
Philpott, emeritus professor of surgery, has always 
felt the need to give back to the school where he 
received his education.
Shortly aer becoming a faculty member, he 
convinced his mother to set up a scholarship fund 
for students. Since then, he’s set up an endowed 
scholarship, donated to annual scholarships and, 
with Kaiser, is leading the effort to bring in more 
money for medical students.
But there was one aspect of giving that Philpott 
never anticipated: how much enjoyment he would 
derive from getting to know the medical students.
“Creating and participating in these scholar-
ships is not only a good thing to do, it’s actually 
fun,” he says. “It keeps us connected with the  
students and the school.”
He and his wife, Susie, stay in touch with their 
scholars, both past and present. Current Philpott 
scholar Marshall C. Strother, a second-year medical 
student, calls the couple “wonderful” and says he 
enjoys spending time with them.
e feeling is mutual.
“e students are so good; they’re bright and 
hard-working,” says Philpott. “We are proud to be 
part of the school’s ongoing scholarship efforts.”
Debt can limit career choices for physicians
Kaiser and Philpott view scholarships as a way  
to help young physicians avoid crushing debt, 
freeing them to make career choices based on 
their unique interests.
“e students ought to always be able to make 
a decision (about specialty) based on their heart,” 
Kaiser says. “If you want to train physicians to go 
into the less highly paid specialties, you have to 
support them.”
Philpott, who spent his career as a faculty 
member, worries that excessive debt load may 
prevent some talented individuals from pursuing 
careers in academic medicine, robbing the future 
of great teachers and investigators.
 “Keeping people in the teaching and academic  
world is one of my personal aims,” says Philpott. 
Susie and Gordon W. Philpott, 
MD, with their students, from 
lower left: Salil H. Desai  
(Class of 2012), Douglas J. 
Dearth Jr. (Class of 2013),  
S. Hassan Akbari (Class of 
2012), and Marshall C.  
Strother (Class of 2014)
“If students are in debt, they feel compelled to pick 
a field, such as the clinical option, that is more 
financially rewarding. I’m worried that teachers 
are going to be hard to find.”
Because cost has become such a critical factor 
in how students choose a medical school, scholar-
ships help attract the very best students.
“Every student who is considering enrolling  
at Washington University School of Medicine has 
already shown a commitment to excellence and a 
desire to keep learning,” says Kaiser. “To continue 
to attract that high quality of student into the  
program, we need to support them.”
for more information, please visit
scholarshipinitiative.wustl.edu
























Charles Fullenwider, MD 43
Fullenwider is a retired ophthalmologist.  
He has traveled to Egypt, West Africa 
and Turkey in the past five years. He also 
enjoys reading, gardening and being a 
member of the Rotary Club.
Elliot D. Luby, MD 49
Luby is professor emeritus of psychiatry 
and law at Wayne State University and 
past president of the Michigan Psychiatric 
Society. The Elliot D. Luby, MD Endowed 
Professorship at Wayne State University 
is currently held by Manuel Tancer, MD.  
Luby’s daughter, Joan L. Luby, MD, is a  
professor of child psychiatry at 
Washington University School of Medicine.
1950 S
James Cunningham, MD 51
Cunningham served in Afghanistan and 
Africa as a visiting orthopedic surgeon 
with a humanitarian organization.  
James Cutter, MD 51
Cutter has been an avid hiker, backpacker 
and photographer throughout many state 
and national parks in California. He has 
one son who is an anesthesiologist and 
one daughter and three granddaughters 
who are registered nurses.
Brent Parker, MD 52
Parker and his wife, Molly, took a driving 
trip to Glacier National Park. They sing 
in their church choir and attend all of 
the symphony concerts. He likes to hike 
in the mountains, lead nature walks in 
the Garden of the Gods, and play tennis. 
Parker is hopeful that he will be able to 
attend his 60th reunion in 2012.
1960 S
John S. Douglas Jr., MD 67
Douglas is professor of medicine and 
director of interventional cardiology and 
the cardiac catheterization laboratory at 
Emory University Hospital in Atlanta GA.  
He enjoys work, golf, gardening and his 
four grandsons. 
1970 S
Robert M. Galatzer-Levy, MD 71
Galatzer-Levy, a child and adolescent 
psychoanalyst, is on the faculty of the 
Chicago Institute for Psychoanalysis and 
the University of Chicago. His latest inter-
ests include chaos theory and false  
confessions. The second edition of his 
book, The Scientific Basis of Child Custody 
Decisions, was published in 2009.
Mark Stitham, MD 75
Stitham continues to be active in his  
avocation of acting, appearing in two  
episodes of the television show “Lost.”
1980 S
Ralph Glasser, MD 81
Glasser is a partner at Associated 
Anesthesiologists of Springfield IL, a 
clinical professor at Southern Illinois 
University in Springfield, and the immedi-
ate past-president of the Illinois Society of 
Anesthesiologists. He has flown for seven 
years as the #5 wingman and lead acrobat-
ics pilot with the Trojan Horsemen Airshow 
Team. Other pastimes include family travel, 
scuba diving with his daughter, and  
collecting Alfa Romeo Spider roadsters.  
1990 S
Maral Kibarian Skelsey, MD 91, HS 95
Skelsey is director of dermatologic sur-
gery at Georgetown University Medical 
Center in Washington DC, and has 
been appointed a consultant to the 
Food and Drug Administration (FDA) 
Committee for (Medical) Devices and 
Radiological Health. She also serves as 
assistant clinical professor of dermatol-
ogy at Georgetown University School of 
Medicine and conducts ongoing research 
related to skin cancer. Skelsey also directs 
the Dermatologic Surgery Center of 
Washington in Chevy Chase MD, an  
outpatient surgical center and  




Scott Lovitch, MD 07
Lovitch recently completed his residency 
in pathology and fellowship in hemato-
pathology, and he is signing out six weeks 
per year on the hematopathology service 
at Brigham. He is also doing postdoctoral 
research in immunology in Arlene Sharpe’s 
(MD, PhD) lab and teaching at Harvard 
Medical School. He and his fiancée are 
planning a July 2012 wedding.
Anjali Gopalan, MD 08
Gopalan has been selected as a 2012 
Robert Wood Johnson Foundation (RWJF) 
Clinical Scholar. She will begin her fellow-
ship in the fall of 2012 at the University 
of Pennsylvania and the Veterans Affairs 
Medical Center.
Sushant Punjaram Kale, MD, MPH, HS 09
Kale recently joined the faculty at 
Southern Illinois University School of 
Medicine as an assistant professor of 
neurology. He also is a member of SIU 
HealthCare, the medical school’s practice 
group, and director of St. John’s Hospital 
Stroke Center. He is married to Shubhangi 
Peche, has one child, and has been  
published in several professional journals.
I M
Ruth Jensen, NU 37
Jensen died on June 28, 2011. She was 
the wife of St. Louis physician J.E. Jensen 
Sr., MD. She was active in Girl Scouts, 
the Missouri Baptist Auxiliary, and Third 
Baptist Church. She is survived by three 
children, six grandchildren and four  
great-grandchildren.
Dorothy M. Kraft, NU 40, NU 42
Kraft, 92, died on May 17, 2011. She 
donated her body to Washington 
University School of Medicine.
Walter J. Kennedy Jr., MD 43
Kennedy, 92, died on March 20, 2011. After 
earning his medical degree, he served in 
the U.S. Army for two years in Omaha NE 
and at Shick General Hospital in Clinton IA. 
He was honored by the Yakima County 
Medical Society, receiving a Fifty Year 
34  Washington University School of Medicine
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If you wish to make a tribute in honor  
of any of the above alumni or faculty, 
please contact: Pamela Buell, Washington 
University Medical Alumni and Development, 
Campus Box 1247, 7425 Forsyth Blvd., St. Louis 
MO 63105, (314) 935-9691.
Service Award, and at 80 years of age he 
tested for and received special certifica-
tion in pediatric neonatology. Kennedy 
was a Diplomate of the American Board 
of Pediatrics and served numerous other 
organizations throughout his career.
Henry Uhlemeyer III, LA 39, MD 43, HS
Uhlemeyer died on August 29, 2011. He 
attended Washington University for his 
undergraduate and medical educations 
and then stayed with the university for 
medical residency training.
William H. Weiss, MD 46
Weiss died on June 27, 2011. After earn-
ing his medical degree, he did a residency 
at the Cleveland Clinic where he trained 
to become an ear, nose and throat physi-
cian. He was most proud of “never losing 
a postsurgical patient or being named in 
a lawsuit.”
Ann Fee, NU 47
Fee, 86, died on June 20, 2011. While 
in nursing school, she met her future 
husband, Wesley S. Fee, MD 44, HS 51.  
After raising their children, they retired, 
sold their cattle ranch on the banks of the 
Tanque Verde, reluctantly surrendered 
their season tickets to Wildcat games, and 
volunteered with the Indian Health Service 
in Alaska for 13 years. Retirement allowed 
them to pursue their love of traveling, 
hunting, scuba diving and fishing. Fee was 
a civic leader and volunteer, supporting 
numerous community organizations.
Herluf G. Lund Sr., MD 49
Lund, 94, died on August 30, 2011. He 
earned both his undergraduate and medi-
cal degrees at Washington University and 
later served in the U.S. Army Medical 
Corps at Fort Gordon GA. He worked on 
the medical staffs of many area hospitals, 
including St. Anthony’s Hospital and 
Lutheran Hospital, where he also served as 
president of the medical staff. The Missouri 
State Medical Association recognized him 
with the 50 Year Membership Award.  
He was an avid golfer and a longtime 
member of the Old Warson Country Club.
Albert Peterman, MD 52
Peterman, 85, died on May 30, 2011. 
Following U.S. Army service during World 
War II, he became committed to having a 
career that focused on saving lives. After 
earning his medical degree, he was a 
resident at Philadelphia General Hospital 
where he met his wife, Nancy DeWitt, 
the chief nurse in the emergency room. 
During training, he discovered a passion 
for neurology, and he later became chief 
of the department and a clinical instructor 
in neurology at Stanford University School 
of Medicine. After practicing for more than 
four decades, he retired in 2001. This first 
retirement did not last long once he real-
ized that golf, travel and the occasional 
Monopoly tournament did not satisfy his 
needs. He entered the workforce again, 
evaluating disability claims submitted to 
the Social Security Administration, a job 
he held until his final retirement in 2010.
Kurt D. Burns, DE 53
Burns, 83, died on July 24, 2011. Follow- 
ing graduation, the Naval Reserve called 
him to active duty, where he served as a 
lieutenant stationed at Camp Pendleton  
in San Diego CA.
Elden H. Mecham, DE 60
Mecham, 82, died on May 20, 2011. He 
practiced for 32 years in Salt Lake City UT. 
He loved reading, history, drawing, model 
airplanes, classical music, ice cream and 
his wife’s famous pie. He and his wife, 
Mary, celebrated 55 years of marriage. 
Wallace M. Kameoka, DE 61
Kameoka, 79, of Mililani HI, died on  
April 30, 2011. He was a U.S. Army  
veteran and was retired from practice.
F 
Harold R. Schreiber, LA 40, DE 47
Schreiber died on Feb. 10, 2011. He 
completed his undergraduate studies at 
Washington University, then served in the 
U.S. Army. After completing his tour, he 
graduated from Washington University 
School of Dental Medicine and became 
a Diplomate of the American Board of 
Periodontology. He continued to serve 
his country as a periodontal consultant to 
the U.S. Fifth Army, Scott Air Force Base 
and the Veterans Administration. He held 
several positions at Washington University 
School of Dental Medicine. Most recently, 
he served as a clinical professor in the 
Graduate Periodontics Department at the 
Saint Louis University Center for Advanced 
Dental Education. He was recognized 
in 2000 with the Gold Medal Award 
by the Greater St. Louis Dental Society 
and, in 2001, was awarded the Lifetime 
Achievement Award from the American 
College of Dentists. 
J. Neal Middelkamp, MD 48
Middelkamp, professor emeritus of pedi-
atrics, died on Nov. 2, 2011. He was 86. 
He spent his entire career at Washington 
University Medical Center, from residency 
at St. Louis Children’s Hospital to joining  
the faculty in the medical school’s 
Department of Pediatrics. He served as 
director of the department’s Division of 
Infectious Diseases and the Division of 
Ambulatory Pediatrics, and he was the 
pediatric clerkship course master for 40 
years. He also served on the Residency 
Review Committee for pediatrics and was 
active in the Office of Graduate Medical 
Education. He was a member of the 
American Board of Pediatrics, including 
the group’s board of directors, and in 
1988 he served as the board’s chairman. 
In 1958, Middelkamp was a fellow of the 
National Foundation/March of Dimes 
and began to study viral diseases affect-
ing children. He received the School of 
Medicine’s Alumni Award in 1988 and its 
Distinguished Alumni Scholarship in 1993. 
He received St. Louis Children’s Hospital’s 
Distinguished Physician Award in 1997. 
Middelkamp and his wife, Lois, also estab-
lished the J. Neal and Lois Middelkamp 
Visiting Professorship in Pediatrics to 
support a pediatric lectureship in infec-
tious diseases and advances in pediatric 
education for medical students, residents 
and pediatricians. He is survived by his 
wife; four children: Sharon Belcher, Steven 
Middelkamp, Susan Crean and Scott 
Middelkamp; a sister; nine grandchildren 
and two great-grandchildren.
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Opening Doors to the Future
The Scholarship Initiative for  
Washington University School of  Medicine
Scholarships ensure
that deserving
students do not miss
the opportunity for
a premier education.
In order to remain affordable for our students and to continue to compete with the nation’s strongest medical schools, the School of Medicine has placed even greater emphasis on philanthropic 
support of scholarships. For more than eight decades, alumni and 
friends have carried on a tradition of scholarship support. 
The cost of a medical education results in an unfair debt load 
for our students, and we are compelled to alleviate this burden. 
Scholarships are the key to allowing future generations of students to 
pursue a career path based on passion, not on potential income.
You may name your scholarship in memory of a loved one, in tribute to a friend, or in honor of yourself,  
your family, or your company. In the fall, a student will be selected to receive your scholarship and you will be notified 
with information about the student. You also will receive an invitation to the annual scholarship dinner.










One hundred years ago the three-dimensional brain remained an 
undiscovered territory. Mapping that territory required precision, 
and a device that showed great promise was described by Sir Victor 
Horsley, a pioneer in neurosurgery, in a 1908 journal article. That 
year, a London-based instrument company made the second such 
device for Ernest Sachs, MD, a young doctor who was studying with 
Horsley. In 1910, the School of Medicine’s Department of Surgery 
recruited Sachs to St. Louis to develop a neurosurgery program. 
The Department of Neurological Surgery  — which celebrated 
the 100th anniversary of neurosurgery at the School of Medicine 
in September — is internationally known for its leadership in 
groundbreaking basic and clinical research, dedication to patient 
care, and training of outstanding residents and fellows. For more 
information, please visit neurosurgery.wustl.edu.
Horsley-Clarke Stereotaxic Instrument
First cited in Horsley, V. and Clarke R.H. The Structure 
and Functions of the Cerebellum Examined by a New 
Method. Brain, v. 31, 1908, pp. 45–124. 
The device, made by Palmer and Company, London, in 
1908, was recently on loan to Becker Medical Library 
from History & Special Collections for the Sciences, 
Library Special Collections, UCLA Louis M. Darling 
Biomedical Library. Exhibition made possible by the 
Barbara and Leon Rootenberg Endowment Fund at the 
UCLA Library. Restoration by David Kopf Instruments.
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Touchdown   With the onset of cooler weather comes the 
southward migration of the Monarch butterfly. On its way to warmer 
climes, this insect stopped to rest atop flora blooming in the plaza of  
the medical center’s newest research facility, the BJC Institute of Health  
at Washington University School of Medicine.
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